Nitric oxide and salt resistance in Dahl rats: No role of inducible NO synthase
In conclusion, inducible NO synthase does not participate in the resistance of SR/Jr rats to hypertensive effects of excess salt intake.PMID:36545880 (Source: Physiological Research)
Source: Physiological Research - December 22, 2022 Category: Physiology Authors: J Zicha L Řezáčová I Van ěčková Source Type: research
Nitric oxide and salt resistance in Dahl rats: No role of inducible NO synthase
In conclusion, inducible NO synthase does not participate in the resistance of SR/Jr rats to hypertensive effects of excess salt intake.PMID:36545880 (Source: Physiological Research)
Source: Physiological Research - December 22, 2022 Category: Physiology Authors: J Zicha L Řezáčová I Van ěčková Source Type: research
Nitric oxide and salt resistance in Dahl rats: No role of inducible NO synthase
In conclusion, inducible NO synthase does not participate in the resistance of SR/Jr rats to hypertensive effects of excess salt intake.PMID:36545880 (Source: Physiological Research)
Source: Physiological Research - December 22, 2022 Category: Physiology Authors: J Zicha L Řezáčová I Van ěčková Source Type: research
Nitric oxide and salt resistance in Dahl rats: No role of inducible NO synthase
In conclusion, inducible NO synthase does not participate in the resistance of SR/Jr rats to hypertensive effects of excess salt intake.PMID:36545880 (Source: Physiological Research)
Source: Physiological Research - December 22, 2022 Category: Physiology Authors: J Zicha L Řezáčová I Van ěčková Source Type: research
Nitric oxide and salt resistance in Dahl rats: No role of inducible NO synthase
In conclusion, inducible NO synthase does not participate in the resistance of SR/Jr rats to hypertensive effects of excess salt intake.PMID:36545880 (Source: Physiological Research)
Source: Physiological Research - December 22, 2022 Category: Physiology Authors: J Zicha L Řezáčová I Van ěčková Source Type: research
Nitric oxide and salt resistance in Dahl rats: No role of inducible NO synthase
In conclusion, inducible NO synthase does not participate in the resistance of SR/Jr rats to hypertensive effects of excess salt intake.PMID:36545880 (Source: Physiological Research)
Source: Physiological Research - December 22, 2022 Category: Physiology Authors: J Zicha L Řezáčová I Van ěčková Source Type: research
Nitric oxide and salt resistance in Dahl rats: No role of inducible NO synthase
In conclusion, inducible NO synthase does not participate in the resistance of SR/Jr rats to hypertensive effects of excess salt intake.PMID:36545880 (Source: Physiological Research)
Source: Physiological Research - December 22, 2022 Category: Physiology Authors: J Zicha L Řezáčová I Van ěčková Source Type: research
Molecules, Vol. 27, Pages 8432: Catechin Reduces Blood Pressure in Spontaneously Hypertensive Rats through Modulation of Arachidonic Acid Metabolism
Conclusion: the modulation of AA metabolism in the kidney contributes, at least partially, to the blood pressure-lowering effect of CAT in SHR rats. (Source: Molecules)
Source: Molecules - December 2, 2022 Category: Chemistry Authors: Fawzy Elbarbry Gabriel Jones Aimy Ung Tags: Article Source Type: research
The Traditional Chinese Medicine Gedan Jiangya Decoction Alleviates Left Ventricular Hypertrophy via Suppressing the Ras/ERK1/2 Signaling Pathway
In conclusion, GJD reduced the Ras/ERK1/2 pathway expression, which decreased hypertension-induced heart hypertrophy. GJD may protect hypertension-induced myocardial hypertrophy by altering gene expression patterns in the heart.PMID:36437833 | PMC:PMC9699742 | DOI:10.1155/2022/6924197 (Source: Evidence-based Complementary and Alternative Medicine)
Source: Evidence-based Complementary and Alternative Medicine - November 28, 2022 Category: Complementary Medicine Authors: Shadi A D Mohammed Hanxing Liu Salem Baldi Pingping Chen Yu Wang Fang Lu Shumin Liu Source Type: research
Blood Pressure Reduction Induced by Chronic Intracerebroventricular or Peroral Clonidine Administration inRats with Salt-Dependent or Angiotensin II-Dependent Hypertension
In conclusions, our results indicate different mechanisms of antihypertensive action of clonidine when administered centrally or systemically.PMID:36426892 (Source: Physiological Research)
Source: Physiological Research - November 25, 2022 Category: Physiology Authors: J Zicha L Řezáčová M Behuliak I Van ěčková Source Type: research
Blood Pressure Reduction Induced by Chronic Intracerebroventricular or Peroral Clonidine Administration inRats with Salt-Dependent or Angiotensin II-Dependent Hypertension
In conclusions, our results indicate different mechanisms of antihypertensive action of clonidine when administered centrally or systemically.PMID:36426892 (Source: Physiological Research)
Source: Physiological Research - November 25, 2022 Category: Physiology Authors: J Zicha L Řezáčová M Behuliak I Van ěčková Source Type: research
Blood Pressure Reduction Induced by Chronic Intracerebroventricular or Peroral Clonidine Administration inRats with Salt-Dependent or Angiotensin II-Dependent Hypertension
In conclusions, our results indicate different mechanisms of antihypertensive action of clonidine when administered centrally or systemically.PMID:36426892 (Source: Physiological Research)
Source: Physiological Research - November 25, 2022 Category: Physiology Authors: J Zicha L Řezáčová M Behuliak I Van ěčková Source Type: research
Current pharmacogenomic recommendations in chronic respiratory diseases: Is there a biomarker ready for clinical implementation?
Expert Rev Respir Med. 2022 Nov 23:1-8. doi: 10.1080/17476348.2022.2149496. Online ahead of print.ABSTRACTINTRODUCTION: The study of genetic variants in response to different drugs has predominated in fields of medicine such as oncology and infectious diseases. In chronic respiratory diseases, the available pharmacogenomic information is scarce but not less relevant.AREAS COVERED: We searched the pharmacogenomic recommendations for respiratory diseases in the Table of Pharmacogenomic Biomarkers in Drug Labeling (U.S. Food and Drug Administration), the Clinical Pharmacogenomics Implementation Consortium (CPIC), and PharmGKB...
Source: Expert Review of Respiratory Medicine - November 23, 2022 Category: Respiratory Medicine Authors: Ingrid Fricke-Galindo Ramc és Falfán-Valencia Source Type: research
